Growing Prevalence of Respiratory diseases to Foster the Growth of the Global Inhaler Market

Published: Dec 2019

The global inhaler market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period (2021-2027). The increasing pervasiveness of respiratory diseases is one of the prime factors affecting and driving the market. Respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD) among others are been observed commonly in people across the globe. As per the World Health Organization (WHO), around 65 million people across the globe suffer from chronic obstructive pulmonary diseases (COPD), and around 334 million are being affected by asthma. Moreover, Chronic Obstructive Pulmonary Disease (COPD) is considered one of the diseases to be ranked 3rd for causing around 3 million death across the globe which in turn is impacting the market. 

Browse the full report description of "Global Inhaler Market Research By Devices (Metered Dose Inhaler, Dry Powder Inhaler, Nebulizer, and Nasal), By Applications (Asthma, and Chronic Obstructive Pulmonary Disease), and By End-User (Home Care, and Hospitals & Clinics) Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/inhaler-market

Further, the increasing case of respiratory diseases would propel the manufacturer to increase the rate of production to meet the demand for inhaler devices for these diseases so that it can lead to achieving improved and effective outcomes for the treatment of diseases. Additionally, another factor that includes remuneration policy along with strategic new launches such as the introduction of smart inhalers is also augmenting the growth and development of the market. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Devices

o By Applications

o By End-User

    • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape - AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc., Koninklijke Philips N.V., and OMRON Healthcare Europe B.V., 

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Inhaler Market Segment

By Devices 

    • Metered Dose Inhaler 

    • Dry Powder Inhaler 

    • Nebulizer 

    • Nasal

By Applications

    • Asthma

    • Chronic Obstructive Pulmonary Disease (COPD)

By End Users

    • Home Care

    • Hospital and Clinics

Global Inhaler Market Segment by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/inhaler-market